Home › Atopic Dermatitis (Eczema) › Alabama
Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Alabama
10 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa Alabama.
Mga Lungsod sa Alabama
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Cahaba Dermatology & Skin Health Center, Birmingham
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07765888A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Birmingham
Nagre-recruitPhase 3
6 Months – 11 Years · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06311682First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07527923Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
- Arcutis Site 324, Birmingham
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07916480A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology & Skin Health Center, Birmingham
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Cahaba Dermatology & Skin Health Center, Birmingham
Nagre-recruitPhase 3
Edad 2 hanggang 11 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06807281This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
- River Region Dermatology and Laser- Site Number : 8400041, Montgomery
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07298395A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.